By Professor David Dang Fung Ma

Journal articles

Moore JJ; Bradstock K; Dodds AJ; Szer J; Smith I; Goh KE; Ma DD, 2004, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic transplantation for AML', Blood, 104, pp. 378B - 378B

Moore JJ; Ma DD; Will R; Cannell P; Handel ML; Milliken ST, 2004, 'A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation', Bone Marrow Transplantation, 34, pp. 241 - 247, http://www.sciencedirect.com/science/article/B6WVB-4CX0S62-K6/2/82576fabf01404bdf5cb9daf484bfd5d

Chang A; Raik E; Marsden K; Ma DD, 2004, 'Australasian CD34(+) quality assurance program and rationale for theclinical utility of the single-platform method for CD34(+) cellenumeration', Cytotherapy, 6, pp. 50 - 61

Brisby H; Tao H; Diwan AD; Ma DD, 2004, 'Cell therapy for disc degeneration - potentials and pitfalls', Orthopedic Clinics of North America, 35, pp. 85 - 93

Chang A; Raik E; Marsden K; Ma DD, 2004, 'Combination of citrate and certain cell counters may result insignificantly different WBCCs (CSI of CD34+QAP)', American Journal of Clinical Pathology, 122, pp. 651 - 652

Moore JJ; Ma DD; Dodds T; Milliken ST; Fay K; Concannon A; smith I, 2004, 'Improved disease survival without increased GVHD using low dose cyclosporine and prednisone in allogeneic stem cell transplantation - A case control study', Blood, 104, pp. 371B - 371B

Nivison-Smith I; Ma DD; Bradstock KF; Szer J; Dodds AJ, 2004, 'Reduced-intensity allogeneic transplants: an update report from theAustralasian Bone Marrow Transplant Recipient Registry', Bone Marrow Transplantation, 33, pp. S104 - S104

Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: comment on the article by Moore et al - Reply', ARTHRITIS AND RHEUMATISM, 48, pp. 1464 - 1466, http://dx.doi.org/10.1002/art.11071

Van Laar JM; Pavletic SZ; Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: Comment on the article by Moore et al [4] (multiple letters)', Arthritis and Rheumatism, 48, pp. 1463 - 1464, http://dx.doi.org/10.1002/art.10982

Figgis PA; Rainer SP; Ma D; Glanville AR, 2003, 'Endobronchial mantle cell lymphoma [2]', Internal Medicine Journal, 33, pp. 261 - 262, http://dx.doi.org/10.1046/j.1445-5994.2003.00393.x

Branford S; Rudzki Z; Haper A; Grigg A; Taylor K; Durrant S; Arthur C; Browett P; Schwarer AP; Ma D; Seymour JF; Bradstock K; Joske D; Lynch K; Gathmann I; Hughes TP, 2003, 'Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase', Leukemia, 17, pp. 2401 - 2409, http://dx.doi.org/10.1038/sj.leu.2403158

Exner T; Joseph JE; Low J; Connor DE; Ma DD, 2003, 'A new activated factor X-based clotting method with improvedspecificity for procoagulant phospholipid', Blood Coagulation and Fibrinolysis: an International Journal in Haemostasis and Thrombosis, 14, pp. 773 - 779

Joseph JE; Courtenay BG; Neil MJ; Mcgrath MA; Ma DD, 2003, 'A single-center prospective study of clinical and genetic thrombophilic risk factors for deep venous thrombosis (DVT) in 510 patients undergoing elective lower limb surgery', Journal of Thrombosis and Haemostasis, pp. 351 - 0351

Connor DE; Joseph JE; Baron D; Muller DW; Roy P; Wilson S; Ma DD, 2003, 'Abciximab therapy post elective coronary artry stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin an dplatelet-monocyte aggregates', Journal of Thrombosis and Haemostasis, pp. 1769 - 1769

Exner T; Joseph JE; Low J; Connor DE; Ma DD, 2003, 'Detection of procoagulants with a more reliable nonactivated clotting test', Journal of Thrombosis and Haemostasis, pp. 1598 - 1598

Tao H; Ma DD, 2003, 'Evidence for transdifferentiation of human bone marrow-derived stem cells: Recent progress and controversies', Pathology, 35, pp. 6 - 13

Moore JJ; Milliken ST; Ma DD; Biggs JC, 2003, 'Letter to the Editor CD34 selected versus unmanipulated grafts for severe rheumatoid arthritis: Reply', Arthritis Care & Research, 48, pp. 1464 - 1466

Exner T; Joseph JE; Low J; Connor DE; Ma DD, 2003, 'Procoagulant phospholipid in blood normally associates mainly with cells or aggregates larger than microparticles or platelets', Journal of Thrombosis and Haemostasis, pp. 1078 - 1078

Hui CH; Goh K; White D; Branford S; Grigg A; Seymour JF; Kwan YL; Walsh S; Hoyt R; Trickett A; Rudzki B; Ma DD; To LB; Hughes TP, 2003, 'Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR', Leukemia, 17, pp. 821 - 828

Moore JJ; Brooks P; Milliken ST; Biggs JC; Ma DD; Handel ML; Will R; Rule S; Joske D; Langlands B; Taylor K; O Callaghan J; Szer J; Wicks I; McColl GJ; Passeullo F; Snowden J, 2002, 'A pilot randomised trial comparing CD34 selected versus unmanipulated haemopoietic stem cell transplanation for severe resistant rheumatoid arthritis', Arthritis Care & Research, 46, pp. 2301 - 2309

Tao H; Rao RS; Ma DD, 2002, 'Transdifferentiation of human haemopoetic lineage negative bone marrow cells to neural cells by cotokines and chemical inducing agent', Blood, 100, pp. 159

Aboud M; Ma DD, 2001, 'Increased incidence of venous thrombosis in patients with shortened activated partial thromboplastin times and low ratios for activated protein C resistance', Clinical and Laboratory Haematology, 23, pp. 411 - 416

Matthews JP; Bishop JF; Young G; Juneja SK; Lowenthal RM; Garson OM; Cobcroft RG; Dodds AJ; Enno A; Gillett EA; Hermann RM; Joshua DE; Ma DD; Szer J; Taylor KM; Wolfe M; Bradstock KF, 2001, 'Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia', British Journal of Haematology, 113, pp. 727 - 736

Moore JJ; Milliken ST; Ma DD; Briggs JW; Brooks P, 2001, 'Peripheral blood stem cell transplantation for rheumatoid arthritis - Australian experience', Journal of Rheumatology, 28, pp. 8 - 12

Mills AK; Taylor KM; Wright SJ; Bunce LH; Bashford J; White K; McLennon R; Ma D; Szer J; Fitzsimmons AJ, 2000, 'Poor yields of peripheral blood stem cells following chlorodeoxyadenosine (2CDA) and VAC treatment for poor-risk, de-novo follicular nonhodgkins lymphoma', Blood, 96

Mills AK; Taylor KM; Wright SJ; Bunce LH; Bashford J; White K; McLennan R; Miles Prince H; Hertzberg M; Ma DF; Kelly CM; Fitzsimmons AJ, 2000, 'Sustained responses following alternating chlorodeoxyadenosine (2CDA) and VAC regimen in poor-risk de-novo follicular non-hodgkin's lymphoma (NHL)', Blood, 96

Moore J; Aboud M; Ma D, 2000, 'Adult transient lupus anticoagulant patients maintain an acquired activated protein C resistance profile', Thrombosis and Haemostasis, 84, pp. 735 - 736, http://dx.doi.org/10.1055/s-0037-1614103

Ma DDF; Rede T; Naqvi NA; Cook PD, 2000, 'Synthetic oligonucleotides as therapeutics: The coming of age', Biotechnology Annual Review, 5, pp. 155 - 196, http://dx.doi.org/10.1016/S1387-2656(00)05035-3

Aboud MR; Ma DDF, 1999, 'Increased incidence of venous thromboembolism in patients with shortened APTT and low APC resistance ratio', THROMBOSIS AND HAEMOSTASIS, pp. 777 - 777, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000085665902466&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ma DDF; Cheong KF; Wong K; Sheather K; Coyle L, 1999, 'Polymorphism of factor V, MTHFR, PAI-1 and prothrombin in patients with venous thromboembolism', THROMBOSIS AND HAEMOSTASIS, pp. 655 - 655, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000085665902076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pecheniuk NM; Cheong KF; Marsh NA; Walsh TP; Ma DDF, 1999, 'Use of the first nucleotide change (FNC) technology to detect Factor V Leiden, prothrombin 20210 and methylene tetrahydrofolate reductase variants in patients with venous thrombosis and coronary artery disease', THROMBOSIS AND HAEMOSTASIS, pp. 666 - 666, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000085665902114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mackinlay N; Aboud M; Roach V; Isbister J; Ma D, 1999, 'Letters to the Editor [1]', Australian and New Zealand Journal of Obstetrics and Gynaecology, 39, pp. 138, http://dx.doi.org/10.1111/j.1479-828X.1999.tb03468.x

Kossard S; Ma DD, 1999, 'Acral keratotic graft versus host disease simulating warts', Australasian Journal of Dermatology, pp. 161 - 163

Naqvi N; Rede T; Bonifacio M; Ma DD, 1999, 'Quantitative analysis of porphyrin-linked oligonucleotides and their biodegraded products by capillary gel electrophoresis using multiple wavelengths', Analytical Biochemistry, pp. 426 - 427

Mackinlay N; Aboud M; Roach V; Isbister J; Ma DD, 1999, 'Resistance to activated protein c in pregnancy and preclampsia', Australian and New Zealand Journal of Obstetrics and Gynaecology, pp. 138 - 139

Turtle CJ; Keefe DM; Bell DJ; Wheeler H; Ma DD, 1999, 'Severe adverse reaction to high epirubicin and cyclosphamide for poor prognosis breast cancer', Australian and New Zealand Journal of Medicine, pp. 275 - 277

Coiffier B; Haioun C; Ketterer N; Engert A; Tilly H; Ma D; Johnson P; Lister A; Feuring-Buske M; Radford JA; Capdeville R; Diehl V; Reyes F, 1998, 'Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study', Blood, 92, pp. 1927 - 1932

Moore J; Ma DDF; Concannon A, 1998, 'Non-malignant bone marrow necrosis: A report of two cases', Pathology, 30, pp. 316 - 318, http://dx.doi.org/10.1080/00313029800169526

Moore J; Ma DD; Concannon A, 1998, 'Non-malignant bone marrow necrosis: a report of two cases.', Pathology, 30, pp. 318 - 320, http://dx.doi.org/10.1080/00313029800169536

Evans J; Percy J; Eckstein R; Ma D; Schnitzler M, 1998, 'Surgery for intestinal graft-versus-host disease: Report of two cases', Diseases of the Colon and Rectum, 41, pp. 1573 - 1576, http://dx.doi.org/10.1007/BF02237309

Hughes TP; Grigg A; Szer J; Ho J; Ma D; Dale BM; Green RM; Norman JE; Sage RE; Herrmann R; Cannell P; Schwarer AP; Taylor K; Atkinson K; Arthur C, 1997, 'Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: Correlation with Sokal prognostic index and haematological control', British Journal of Haematology, 96, pp. 635 - 640, http://dx.doi.org/10.1046/j.1365-2141.1997.d01-2068.x

Aboud MR; Ma DDF, 1997, 'A comparison between two activated protein C resistance methods as routine diagnostic tests for factor V Leiden mutation', British Journal of Haematology, 97, pp. 798 - 803, http://dx.doi.org/10.1046/j.1365-2141.1997.1432958.x

Le Doan T; Étoré F; Ma DDF; Tenu JP, 1996, 'Perspectives d'une chimiothérapie plus sélective avec les oligonucléotides antisens', Annales De Medecine Interne, 147, pp. 542 - 552

Arthur CK; Enno A; Firkin F; Ma D; Iland H; Concannon A; Young G; Shaw P; Gallo J; Hertzberg M, 1996, 'A dose escalation study of high dose interferon alpha 2a (HDIFN) up to 18 million units daily in patients with poor prognosis chronic myeloid leukemia (CML) or good prognosis patients who have failed treatment with IFN plus cytosine arabinoside (ARA-C)', BLOOD, 88, pp. 2291 - 2291, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VT98302291&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hughes TP; Grigg A; Szer J; Ho J; Ma D; Dale BM; Green RM; Norman JE; Sage RE; Herrmann R; Cannell P; Schwarer AP; Taylor K; Atkinson K; Arthur C, 1996, 'Mobilization of predominantly Ph-negative blood progenitors using cyclophosphamide and lenograstim in early chronic phase CML: Correlation with Sokal prognostic index and hematological control pre-mobilisation.', BLOOD, 88, pp. 927 - 927, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VT98300927&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ma DDF; Wei AQ, 1996, 'Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes', Leukemia Research, 20, pp. 925 - 930, http://dx.doi.org/10.1016/S0145-2126(96)00062-8

Chang A; Ma DDF, 1996, 'An Australian multi-centre study assessing the variability of CD34+ cell measurement for PB stem cell transplantation', BRITISH JOURNAL OF HAEMATOLOGY, 93, pp. 907 - 907, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996UP11400907&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Straetmans N; Ma DDF; Nevell DF; Arthur C, 1996, 'Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-c therapy', HEMATOPATHOLOGY AND MOLECULAR HEMATOLOGY, 10, pp. 213 - 222, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996WG50400005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chang A; Ma DDF, 1996, 'The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: An Australian multicenter study', Journal of Hematotherapy and Stem Cell Research, 5, pp. 605 - 616, http://dx.doi.org/10.1089/scd.1.1996.5.605

Chang A; Ma DD, 1996, 'The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australasian BMT Scientists Study Group.', J Hematother, 5, pp. 605 - 616, http://dx.doi.org/10.1089/scd.1.1996.5.605

Back to profile page